APCS and primary systemic amyloidosis: SAP deficiency produces no abnormal phenotype inunchallenged mice, and since sustained almost complete SAP depletion in humanpatients with systemic amyloidosis, osteoarthritis or Alzheimer's disease has had noadverse effects, we consider it neither necessary nor ethical to investigate theeffects of large doses of isolated human SAP in volunteers.